Controversies in the Treatment of Lymphoma with Autologous Transplantation-Reference-Cited by-同舟云学术

Controversies in the Treatment of Lymphoma with Autologous Transplantation

Published:2009-09-01 Issue:9 Volume:14 Page:921-929
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Moskowitz Alison J.¹,Moskowitz Craig H.¹

Affiliation:

1. Lymphoma Service, Memorial-Sloan Kettering Cancer Center, New York, New York, USA

Abstract

Learning Objectives After completing this course, the reader will be able to: Appraise the available data supporting the use of autologous stem cell transplant in follicular lymphoma, mantle cell lymphoma, and peripheral T-cell lymphoma.Discuss the appropriate role of autologous stem cell transplant in the treatment of follicular lymphoma, mantle cell lymphoma, and peripheral T-cell lymphoma.Outline the areas of investigation regarding mobilization, conditioning, and maintenance regimens for autologous stem cell transplant in follicular lymphoma, mantle cell lymphoma, and peripheral T-cell lymphoma. This article is available for continuing medical education credit at CME.TheOncologist.com

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.2009-0162

Reference51 articles.

1. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma;Philip;N Engl J Med,1995

2. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin’s disease: Results of a BNLI randomised trial;Linch;Lancet,1993

3. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin’s disease: A randomised trial;Schmitz;Lancet,2002

4. New approach to classifying non-Hodgkin’s lymphomas: Clinical features of the major histologic subtypes. Non-Hodgkin’s Lymphoma Classification Project;Armitage;J Clin Oncol,1998

5. Patterns of survival in patients with recurrent follicular lymphoma: A 20-year study from a single center;Johnson;J Clin Oncol,1995

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripheral blood stem cells mobilization in patients with relapsed or refractory lymphomas: A single-center experience;Journal of Cancer Research and Therapeutics;2023-12-15

2. BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) Versus BEAM (Carmustine, Etoposide, Cytarabine, Melphalan) as Conditioning Regimen Before Autologous Haematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis;Cell Transplantation;2023-01

3. Stem Cell Transplant for Hodgkin Lymphoma;Basics of Hematopoietic Stem Cell Transplant;2023

4. A Retrospective Comparison of Mitoxantrone-Melphalan and BEAM Conditioning Regimens Before Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Lymphoma Patients;Indian Journal of Hematology and Blood Transfusion;2021-05-05

5. A Comparison of the BEAM and MITO/MEL Conditioning Regimens for Autologous Hematopoietic Stem Cell Transplantation in Hodgkin Lymphoma: An Analysis of Efficiency and Treatment-Related Toxicity;Clinical Lymphoma Myeloma and Leukemia;2020-10